Skip to content
The Nexus
DossierENTITY

Illumina

Coverage of Illumina in the Nexus archive.

Earliest in view: Jun 12 · 12:41 UTCMost recent: Jun 16 · 08:30 UTC
Co-mentioned in this coverage
International Human Cell Atlas Consortiumorganization1Aviv Regevperson1David Altshulerperson1Eric Landerperson110x Genomicsorganization1spatial biologytopic1Vizgenorganization1Institut Pasteur de Dakarorganization1Oxford Nanopore Technologiesorganization1early-onset breast cancertopic1rare heritable gene changestopic1Genomicstopic1infectious diseasestopic1cancertopic1
Recent coverage
  • SCIENCEJun 16 · 08:30 UTCSTAT NEWS
    STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions

    The International Human Cell Atlas Consortium is hosting a major meeting in Boston, featuring leaders like Aviv Regev and Eric Lander, as it advances toward publishing its first draft of a comprehensive human cell map. The project faces potential conflict-of-interest concerns due to its reliance on 10x Genomics' technology, which is now competing with other emerging spatial biology tools from companies like Vizgen and Illumina.

  • HEALTHJun 12 · 12:41 UTCALLAFRICA
    Senegal: Institut Pasteur de Dakar Sequences the First Human Whole Genomes in the Country and Launches an Early Cancer Detection Platform

    Institut Pasteur de Dakar has sequenced the first 40 human whole genomes in Senegal using Illumina and Oxford Nanopore Technologies. The institution launched a clinical laboratory and bioinformatics platform for testing early-onset breast cancer predisposition and rare heritable gene changes. A multidisciplinary research program integrating genomics, infectious diseases, and environmental factors aims to address cancer's growing burden in Senegal and Africa.